The MetNI transporter drives methionine import against its concentration gradient and regulates intracellular methionine levels. Results: Methionine is a noncompetitive inhibitor of MetNI ATPase activity, binding the transporter at two allosteric sites. Conclusion: MetNI regulates intracellular methionine concentrations via allosteric regulation. Significance: Regulation of methionine import at the protein level may minimize wasteful consumption of ATP when adequate intracellular supplies are available.
ing pockets are created at this dimerization interface, physical separation of the NBDs will prevent ATP binding and hydrolysis, thereby inhibiting transport (see Fig. 1B ) (11) . MetNI provides a rare opportunity to develop detailed kinetic and thermodynamic analyses to study the mechanism of a structurally characterized ABC transporter. As a starting point, we examine the kinetics of ATP hydrolysis to elucidate the mechanism of MetNI transinhibition. To focus on the inhibitory effects of methionine, we employed a basic experimental system consisting of detergent-solubilized MetNI in the absence of MetQ, the substrate-containing cognate periplasmic binding protein. Although MetQ will clearly influence the structure and activity of MetNI (see Ref. 17 for an informative discussion of the maltose transport system), it will also complicate an analysis of the role of methionine because the stimulating effect of MetQ on the ATPase activity is opposite of the allosteric effect of methionine. As a consequence, we have not included MetQ in these studies. Additionally, the basal ATPase activity of detergent-solubilized ABC transporters typically increases and the coupling efficiency decreases, relative to the behavior in a phospholipid bilayer, as again exemplified by the maltose transporter (see Ref. 18) . Although ATPase activity uncoupled to transport is not the physiological reaction of ABC transporters, comparisons of ABC subunits in isolation and in transporters are suggestive of a common mechanism for ATP hydrolysis (19) . Consequently, meaningful kinetic interpretations can be derived from the effects of methionine on the relative ATPase activity of MetNI in our simplified system. We find that transinhibition is due to noncompetitive inhibition by L-methionine and that there are two allosteric methionine binding sites per transporter. These findings are consistent with the structurally based model for transinhibition and could be extended to understanding the regulation of the broader ABC family.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification-The wild-type Histagged MetNI expression plasmid (11) was transformed into BL21-Gold (DE3) cells (Novagen). Cell growth was carried out at 37°C in Terrific Broth containing 1% glucose and 100 g/ml ampicillin. Protein expression was induced by the addition of isopropyl ␤-D-1-thiogalactopyranoside to 1 mM for 1 h. Cells were harvested by centrifugation and stored at Ϫ80°C.
Frozen cell pellets were homogenized in purification buffer (50 mM TAPS, pH 8.5, 250 mM NaCl, 0.05% n-dodecyl-␤-D-maltopyranoside (DDM, Anatrace)) supplemented with DNase, lysozyme, and protease inhibitor tablets (Roche Diagnostics GmbH). To extract MetNI protein, DDM was added to 1.0% final concentration. Cells were stirred at 4°C for 20 min and then passed through a Microfluidizer three times. The cell lysate was stirred for 20 min and then spun for 20 min at 16,000 rpm in a JLA 17 rotor. The supernatant was recovered, and imidazole was added to 25 mM final concentration. The supernatant was then flowed over three tandem 5-ml HisTrap FF columns (GE Healthcare) and washed with 2 column volumes of purification buffer containing 25 mM imidazole and 5 column volumes of purification buffer containing 75 mM imidazole. MetNI protein was eluted with purification buffer containing 350 mM imidazole. Eluate was then buffer-exchanged into purification buffer without imidazole using a HiPrep 26/10 desalting column (GE Healthcare). The protein was then sized over a Superdex 200 column (GE Healthcare) and concentrated to ϳ60 M in an Amicon Ultra 100-kDa molecular mass cutoff centrifugal filter (Millipore) prewashed in purification buffer. Purified protein was flash-frozen in LN 2 and stored at Ϫ80°C.
ATPase Assays-The amount of inorganic phosphate generated in solution was measured in real time using the Enzchek phosphate assay kit (Molecular Probes). Each 100-l reaction contained 60 mM Tris, pH 7.5, 5 mM TAPS, pH 8.5, 0.055% DDM, 55 mM NaCl, 200 M 2-amino-6-mercapto-7-methylpurine riboside, 0.1 units of purine nucleoside phosphorylase, equimolar amounts of MgCl 2 and ATP and/or ADP, and L-methionine as indicated. Data were collected on an Infinite M200 microplate reader (Tecan Group) at 33°C. Reactions were incubated for 2 min and then initiated by automatic injection of MetNI (supplemental Fig. S1 ). For measurement of K I(ADP) , 3 M MetNI final concentration was injected into reactions containing 100 M MgATP. For all other measurements, reactions contained 410 nM MetNI. Initial rates were obtained by calculating the linear portion of the change in absorbance at 360 nm as a function of time using Magellan software. Error bars represent S.E. from at least three independent experiments.
All data were fit using KaleidaGraph (Synergy Software). For determination of K I values, the initial rate was plotted against inhibitor concentration and fit to the following equation
where [I] is the inhibitor concentration, K I is the inhibition constant, and n I is the Hill coefficient for the inhibitor. For determination of K m(ATP) , V max , and the Hill coefficient n ATP , the initial rate was plotted against ATP concentration and fit to the following equation
Isothermal Titration Calorimetry-MetNI was further concentrated to 350 -450 M in an Amicon Ultra 100-kDa molecular mass cutoff centrifugal filter (Millipore) prewashed in purification buffer. Samples were then dialyzed overnight in purification buffer in 100-kDa molecular mass cutoff Slide-aLyzer MINI dialysis devices (Thermo Scientific). The next day, samples were recovered and cleared at 95,000 rpm for 10 min in a TLA100 rotor. L-Methionine (BioUltra, Sigma) was reconstituted in the purification buffer used for dialysis. Binding data were collected on a MicroCal iTC-200 calorimeter at 25°C. 300 -450 M MetNI was titrated with 8 -10 mM L-methionine. For each experiment, an initial injection of 0.4 l was followed by 19 injections of 2 l each. The sample cell was allowed to equilibrate for 180 s between titrations. Data were processed using Origin v7.0 (OriginLab). Error bars represent S.E. from at least three independent experiments.
RESULTS
To establish the kinetic mechanism of transinhibition, we measured the ATPase activity of detergent-solubilized, wild-type MetNI using a continuous spectrophotometric coupled enzymatic assay (see "Experimental Procedures"). To define the basic parameters of the assay, MetNI was automatically injected into reactions containing varying concentrations of MgATP. The initial rates were plotted and fit to a sigmoidal curve with K m ϭ 330 Ϯ 20 M and a Hill coefficient of 1.7 Ϯ 0.1, indicating positive cooperativity between the two ATP binding pockets ( Fig. 1C and supplemental  Fig. S1 ). Cooperative binding of ATP is a common feature of several ABC transporters, including the vitamin B12, maltose, and histidine transporters (20 -23) .
We then verified the competitive nature of nucleotide inhibition of MetNI ATPase activity. Because canonical nucleotide analogs for ATP, including AMPPNP, AMPPCP, and ATP␥S, did not completely inhibit ATPase activity in the concentration range tested (data not shown), we measured ATPase inhibition using ADP. Under subsaturating ATP concentrations, ADP inhibited MetNI ATPase activity with a K I(ADP) of 41 Ϯ 2 M and a Hill coefficient of 1.3 Ϯ 0.1, indicating low cooperativity for the binding of ADP ( Fig. 2A and Table 1 ). Next, the ATP concentration was varied under constant ADP concentrations both above and below the measured K I(ADP) . In the presence of ADP, the apparent V max remained unchanged, whereas the apparent K m increased with increasing inhibitor concentration ( Fig. 2B and Table 2 ). As expected, these experiments confirmed that ADP is indeed a competitive inhibitor.
We next tested L-methionine inhibition of MetNI ATPase activity. Inhibition experiments under saturating ATP concentrations were fit to a K I(L-Met) of 41 Ϯ 1 M and a Hill coefficient of 1.4 Ϯ 0.1, indicating that there is more than one methionine binding site per MetNI transporter and low cooperativity between the sites (Fig. 3A and Table 1 ). Furthermore, with increasing L-methionine concentrations, the apparent V max significantly decreased, whereas the apparent K m remained constant (Fig. 3B and Table 2 ). These data suggest that L-methionine is a noncompetitive inhibitor of MetNI ATPase activity. To further support this model, we conducted isothermal titration calorimetry experiments using L-methionine as the ligand (Fig. 3C) 
DISCUSSION
We have demonstrated that L-methionine can bind to MetNI at allosteric sites, resulting in the noncompetitive inhibition of ATP hydrolysis. This direct modulation of MetNI activity is consistent with the model based on the crystallographically observed ATPase-inactive state of MetNI. Our data suggest that the transinhibition phenomenon observed by Kadner (3) can be attributed to the regulation of methionine import at the protein activity level. The de novo biosynthesis of methionine in E. coli is costly, requiring 7 ATPs and 8 NADPHs per molecule of methionine (24) . If extracellular methionine is available, uptake of the exogenous methionine at an estimated cost of ϳ2 ATPs per methionine molecule would be energetically preferable to de novo biosynthesis. The homeostatic intracellular concentration of methionine is estimated to be 150 M (25), maintained by the balance between the rate of appearance of methionine via the MetNI import system and/or the methionine biosynthesis pathway and the rate of disappearance via protein synthesis and other processes. Given the K I for methionine inhibition measured in this study (ϳ40 M), uptake should occur under conditions when the intracellular levels of methionine are well below 150 M, with the rate of transport decreasing as the interior concentration increases. Several aspects of our study are worth detailing. We have kinetically analyzed the influence of methionine on the ATPase activity of detergent-solubilized MetNI in the absence of the MetQ binding protein and in the absence of phospholipid. For the kinetic analysis, we have used the simplest models for noncompetitive and competitive inhibition to treat the effects of methionine and ADP, respectively, on ATPase activity. These models do not include binding interactions between ligands. We have explored more complex kinetic models (see the supplemental text), which suggest that little interaction occurs in the binding of these ligands. Given the correlation of parameters intrinsic to these binding models (26), it is not possible to confidently assess the magnitudes of these effects. The MetQ binding protein was not utilized in these studies to avoid the opposing effects of methionine on ATPase activity due to transport (requiring methionine-bound MetQ) and to transinhibition (requiring methionine acting as an allosteric ligand). We have focused on detergent-solubilized MetNI to directly characterize the influence of methionine on the ATPase activity of the form of MetNI that has been crystallographically characterized. Although the physiological function of ABC transporters requires membranes, detergent-solubilized transporters can capture important functional properties. The most extensive mechanistic studies of ABC importers have been conducted for the MalFGK 2 transporter; although the detailed properties differ, the cooperativity of ATP hydrolysis can be observed for both detergent-solubilized and proteoliposome-reconstituted ABC transporters (22) . Furthermore, complexes between the maltose transporter and binding protein can be trapped using ATP ϩ vanadate with either membrane-bound or detergentsolubilized transporter (27) . Unquestionably, the structural studies on detergent-solubilized maltose transporter from the Chen group (14, 17) and on detergent-solubilized vitamin B12 transporter from the Locher group (20, 28) have provided an invaluable framework for the interpretation of mechanistic studies of transport in proteoliposomes.
ABC transporters have adopted a wide range of mechanisms to regulate their activity. The molybdate/tungstate transporter ModBC shares a similar architecture with MetNI and also demonstrates transinhibitory behavior at higher concentrations of substrate (13) . The maltose transporter, in contrast, is regulated by an additional protein that responds to nutrient availability. Unphosphorylated EIIA Glc binds MalFGK 2 when preferred sources of carbon, such as glucose, are available (29) . Two EIIA Glc molecules bind the NBDs and promote the inwardfacing conformation reminiscent of the MetNI inhibited (30) . Quantitative modeling of our MetNI data suggests that methionine may similarly inhibit ATP hydrolysis but not ATP binding (see the supplemental text).
Although the above examples highlight inhibition as the result of a stabilized inward-facing conformation, ABC transporters are also regulated at the level of transcription, glycosylation, and direct phosphorylation. For example, the osmoregulatory transporter OpuA is regulated by the transcription factor OpuR in response to osmotic stress (31) . CFTR (cystic fibrosis transmembrane conductance regulator), an ABC-type chloride channel whose malfunction is linked to cystic fibrosis, is gated by PKA-mediated phosphorylation of its cytoplasmic regulatory domain (32) (33) (34) (35) . Lastly, it is hypothesized that glycosylation may help stabilize the rod photoreceptor ABC transporter (ABCR) against degradation while in the endoplasmic reticulum (36) .
The regulation of ABC transporters, whether through accessory proteins, regulatory domains, or posttranslational modifications, is critical to balance the transport of metabolites for optimal growth. The MetNI transporter, through transinhibition, is effectively able to shut off import when adequate intracellular methionine is available for crucial cellular processes. A possible mechanism for this phenomenon envisioned nearly 40 years ago by Kadner (3) on the basis of transport studies in E. coli cells (" . . . internal methionine binds to the carrier on the internal face of the membrane. This methionine-carrier complex might be unable, or at least less able, to undergo the energy-dependent change necessary for active transport . . . ") was prescient, as the present studies have established using purified components. Significantly, the underlying mechanism (ligand binding to regulatory domains inhibits NBD dimerization, thereby preventing ATP hydrolysis and effectively "turning off the engine") exemplifies a broadly relevant mechanism for regulating the activity of ABC transporters at the protein level. 
